The White House is keeping the pressure on Senate Finance Committee members as they negotiate final details of drug-price control legislation the last week before the July 4 recess, after which Finance is expected to release its drug-pricing plan . A day after Senate Finance Chair Chuck Grassley (R-IA) said he opposed the administration’s plan to rely on foreign drug-price controls, White House budget officials began reviewing that plan , and on Friday HHS Secretary Alex Azar touted the proposal...